查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869854

麻醉和呼吸设备市场规模、份额和趋势分析报告：按产品、地区和细分市场预测（2025-2033 年）

Anesthesia And Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Respiratory Devices, Anesthesia Devices), By Region (North America, Europe, Asia Pacific, Latin America), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 250 Pages | 商品交期: 2-10个工作天内

价格

麻醉和呼吸设备市场摘要

2024年全球麻醉和呼吸设备市场规模预计为563亿美元，预计到2033年将达到915亿美元，2025年至2033年的复合年增长率为5.6%。

推动该行业发展的因素包括：阻塞型睡眠呼吸中止症（OSA）和慢性阻塞性肺病（COPD）等呼吸系统疾病发病率上升、快速都市化、外科手术数量增加、污染水平上升、人口老龄化以及吸烟者数量增加。

例如，根据澳洲健康与福利研究所的数据，2023 年慢性阻塞性肺病占呼吸系统疾病总负担的 50%，占疾病总负担的 3.6%。此外，美国肺臟协会报告称，2022 年有 4.6% 的成年人（1,170 万人）被诊断患有慢性支气管炎、慢性阻塞性肺病或肺气肿。

吸烟人群的增加也导致肺气肿、支气管炎、癌症和其他肺部疾病等呼吸系统疾病的发生率上升，刺激了对呼吸设备的需求，并推动了市场成长。根据世界卫生组织2023年7月发布的数据，烟草使用每年在全球造成超过800万人死亡，其中超过700万人死于直接吸烟，约130万人死于非吸烟者被动吸烟。

目录

第一章调查方法和范围

第二章执行摘要

3. 麻醉和呼吸设备市场变数、趋势和范围

  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会
  • 麻醉和呼吸设备市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章 麻醉和呼吸设备市场：按产品分類的估算和趋势分析

  • 产品类型市场份额，2024 年和 2033 年
  • 细分仪表板
  • 按产品类型分類的市场展望
    • 麻醉设备
    • 呼吸装置

第五章 麻醉和呼吸设备市场：按产品分類的区域估算和趋势分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场概览
  • 全球区域市场概览
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 主要企业市占率/地位分析，2024年
  • 公司简介
    • Medtronic
    • Teleflex Incorporated
    • Koninklijke Philips NV
    • Dragerwerk AG &Co. KGaA
    • Getinge AB.
    • Smiths Group plc
    • Fisher &Paykel Healthcare Limited.
    • Masimo
    • B. Braun Melsungen AG
    • ResMed
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
    • Inogen, Inc.
    • Caire Medical（a subsidiary of NGK Spark Plug）
    • DeVilbiss Healthcare（a subsidiary of Drive Medical）.
    • React Health（Respiratory Product Line from Invacare Corporation）
    • O2 Concepts
    • Nidek Medical Products, Inc.
    • Omron Corporation
    • GE Healthcare
    • Allied Healthcare
    • Vectura Group Plc.
    • PARI Respiratory Equipment, Inc.
    • Aerogen
    • Beurer
    • Briggs Healthcare
Product Code: 978-1-68038-557-1

Anesthesia And Respiratory Devices Market Summary

The global anesthesia and respiratory devices market size was estimated at USD 56.3 billion in 2024 and is expected to reach USD 91.5 billion by 2033, growing at a CAGR of 5.6% from 2025 to 2033. The industry is driven by an increased incidence of respiratory disorders such as Obstructive Sleep Apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD), fast urbanization, an increase in surgical operations, pollution levels, a geriatric population, and a smoking population.

For instance, according to the Australian Institute of Health and Welfare, in 2023, COPD accounted for 50% of the total burden of disease due to respiratory conditions and 3.6% of the total disease burden. Furthermore, according to the American Lung Association, in 2022, 4.6% of adults, or 11.7 million people, reported a diagnosis of chronic bronchitis, COPD, or emphysema.

The rising population of smokers is also leading to the increasing incidence of respiratory diseases, such as emphysema, bronchitis, cancer, and other lung diseases, which is leading to the growing demand for respiratory devices, hence boosting the market growth. According to WHO data published in July 2023, tobacco use is responsible for over 8 million deaths annually worldwide. Of these, more than 7 million are attributed to direct tobacco consumption, while approximately 1.3 million are due to second-hand smoke exposure among non-smokers.

Global Anesthesia And Respiratory Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global anesthesia and respiratory devices market report based on product and region:

  • Product Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Respiratory Devices
    • Respiratory Equipment
    • Humidifiers
    • Heat Humidifiers
    • Heated Wire Breathing Circuits
    • Heat Exchangers
    • Pass Over Humidifiers
    • Nebulizers
    • Pneumatic Nebulizers
    • Mesh Nebulizers
    • Ultrasonic Nebulizers
    • Oxygen Concentrator
    • Fixed Oxygen Concentrators
    • Portable Oxygen Concentrators
    • Positive Airway Pressure Devices
    • Bilevel & automatic positive airway pressure devices
    • Continuous positive airway pressure devices
    • Reusable Resuscitators
    • Ventilators
    • Adult Ventilators
    • Neonatal Ventilators
    • Respiratory Inhalers
    • Dry Powdered Inhalers
    • Metered Dose Inhaler
    • Respiratory Disposables
    • Disposable Oxygen Masks
    • Resuscitators
    • Tracheostomy Tubes
    • Oxygen Cannula
    • Respiratory Measurement Devices
    • Pulse Oximetry systems
    • Capnographs
    • Spirometers
    • Peak Flowmeters
  • Anesthesia Devices
    • Anesthesia Machines
    • Anesthesia Workstation
    • Anesthesia delivery machines
    • Portable
    • Standalone
    • Anesthesia Ventilators
    • Anesthesia Monitors
    • Anesthesia Disposables
    • Anesthesia Masks
    • Anesthesia Accessories
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product outlook
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
      • 3.1.1.1. Rise In Chronic Respiratory Diseases And Geriatric Population
      • 3.1.1.2. Technological Advancements
      • 3.1.1.3. Supportive Initiatives by Government and Private Organizations
    • 3.1.2. Market Restraint analysis
      • 3.1.2.1. Product Recalls & Failure
      • 3.1.2.2. Complexity of Modern Anesthesia and Respiratory Machines
    • 3.1.3. Market Opportunities
  • 3.2. Anesthesia and Respiratory Devices Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape

Chapter 4. Anesthesia and Respiratory Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Type Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Brain Computer Interface Market by Product Type Outlook
    • 4.3.1. Anesthesia Devices
      • 4.3.1.1. Anesthesia Devices market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.1.1.1. Anesthesia Machines
          • 4.3.1.1.1.1. Anesthesia Machines market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.2. Anesthesia Workstation
            • 4.3.1.1.1.2.1. Anesthesia Workstation market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.3. Anesthesia Delivery Machines
            • 4.3.1.1.1.3.1. Anesthesia Delivery Station market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.1.1.1.3.2. Portable Anesthesia Delivery Machine
              • 4.3.1.1.1.3.2.1. Portable Anesthesia Delivery Machine market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.1.1.1.3.3. Standalone Anesthesia Delivery Machine
              • 4.3.1.1.1.3.3.1. Standalone Anesthesia Delivery Machine market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.4. Anesthesia Ventilators
            • 4.3.1.1.1.4.1. Anesthesia Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.5. Anesthesia Monitors
            • 4.3.1.1.1.5.1. Anesthesia Monitors market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.1.1.2. Anesthesia Disposables
          • 4.3.1.1.2.1. Anesthesia Disposables market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.2.2. Anesthesia Masks
            • 4.3.1.1.2.2.1. Anesthesia Masks market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.2.3. Anesthesia Accessories
            • 4.3.1.1.2.3.1. Anesthesia Accessories market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Respiratory Devices
      • 4.3.2.1. Respiratory devices market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.1.1. Respiratory Equipment
          • 4.3.2.1.1.1. Respiratory Equipment's market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.2. Humidifiers
            • 4.3.2.1.1.2.1. Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.2.2. Heat Humidifiers
              • 4.3.2.1.1.2.2.1. Heat Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.2.3. Heated wire breathing circuits
              • 4.3.2.1.1.2.3.1. Heated wire breathing circuits market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.2.4. Heat Exchangers
              • 4.3.2.1.1.2.4.1. Heat Exchangers market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.2.5. Pass Over Humidifiers
              • 4.3.2.1.1.2.5.1. Pass Over Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.3. Nebulizers
            • 4.3.2.1.1.3.1. Nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.3.2. Pneumatic nebulizers
              • 4.3.2.1.1.3.2.1. Pneumatic nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.3.3. Mesh nebulizers
              • 4.3.2.1.1.3.3.1. Mesh nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.3.4. Ultrasonic nebulizers
              • 4.3.2.1.1.3.4.1. Ultrasonic nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.4. Oxygen Concentrators
            • 4.3.2.1.1.4.1. Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.4.2. Fixed Oxygen Concentrators
              • 4.3.2.1.1.4.2.1. Fixed Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.4.3. Portable Oxygen Concentrators
              • 4.3.2.1.1.4.3.1. Portable Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.5. Positive airway pressure devices
            • 4.3.2.1.1.5.1. Positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.5.2. Bi-level positive airway pressure devices
              • 4.3.2.1.1.5.2.1. Bi-level positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.5.3. Continuous positive airway pressure devices
              • 4.3.2.1.1.5.3.1. Continuous positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.6. Reusable resuscitators
            • 4.3.2.1.1.6.1. Reusable resuscitators market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.7. Ventilators
            • 4.3.2.1.1.7.1. Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.7.2. Adult Ventilators
              • 4.3.2.1.1.7.2.1. Adult Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.7.3. Neonatal Ventilators
              • 4.3.2.1.1.7.3.1. Neonatal Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.8. Respiratory inhalers
            • 4.3.2.1.1.8.1. Respiratory inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.8.2. Dry Powdered Inhalers
              • 4.3.2.1.1.8.2.1. Dry Powdered Inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.8.3. Metered Dose Inhalers
              • 4.3.2.1.1.8.3.1. Metered Dose Inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.9. Respiratory disposable
            • 4.3.2.1.1.9.1. Respiratory disposable market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.9.2. Disposable Oxygen Mask
              • 4.3.2.1.1.9.2.1. Disposable oxygen mask market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.9.3. Resuscitators
              • 4.3.2.1.1.9.3.1. Resuscitators market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.9.4. Tracheostomy Tubes
              • 4.3.2.1.1.9.4.1. Tracheostomy Tubes market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.9.5. Oxygen Cannula
              • 4.3.2.1.1.9.5.1. Oxygen Cannula market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.2.1.1.10. Respiratory measurement devices
            • 4.3.2.1.1.10.1. Respiratory measurement devices market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.10.2. Pulse oximetry systems
              • 4.3.2.1.1.10.2.1. Pulse oximetry systems market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.10.3. Capnographs
              • 4.3.2.1.1.10.3.1. Capnographs market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.10.4. Spirometers
              • 4.3.2.1.1.10.4.1. Spirometers market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.3.2.1.1.10.5. Peak flowmeters
              • 4.3.2.1.1.10.5.1. Peak flowmeters market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Anesthesia and Respiratory Devices Market: Regional Estimates & Trend Analysis, By Product

  • 5.1. Regional Market Share Analysis, 2024 & 2033
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. North America
    • 5.4.1. U.S.
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Canada
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Mexico
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Europe
    • 5.5.1. UK
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.3. France
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.4. Italy
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.5. Spain
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.6. Norway
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key country dynamics
      • 5.5.8.2. Regulatory framework/ reimbursement structure
      • 5.5.8.3. Competitive scenario
      • 5.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Japan
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.2. China
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.3. India
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.4. Australia
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.6. Thailand
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Brazil
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.2. Argentina
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. MEA
    • 5.8.1. South Africa
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.8.2. Saudi Arabia
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.8.3. UAE
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Regulatory framework/ reimbursement structure
      • 5.8.3.3. Competitive scenario
      • 5.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.8.4. Kuwait
      • 5.8.4.1. Key country dynamics
      • 5.8.4.2. Regulatory framework/ reimbursement structure
      • 5.8.4.3. Competitive scenario
      • 5.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Key company market share/position analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Medtronic
      • 6.4.1.1. Company Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Teleflex Incorporated
      • 6.4.2.1. Company Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Koninklijke Philips N.V.
      • 6.4.3.1. Company Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Dragerwerk AG & Co. KGaA
      • 6.4.4.1. Company Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Getinge AB.
      • 6.4.5.1. Company Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Smiths Group plc
      • 6.4.6.1. Company Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Fisher & Paykel Healthcare Limited.
      • 6.4.7.1. Company Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Masimo
      • 6.4.8.1. Company Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. B. Braun Melsungen AG
      • 6.4.9.1. Company Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. ResMed
      • 6.4.10.1. Company Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic initiatives
    • 6.4.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
      • 6.4.11.1. Company Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic initiatives
    • 6.4.12. Inogen, Inc.
      • 6.4.12.1. Company Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic initiatives
    • 6.4.13. Caire Medical (a subsidiary of NGK Spark Plug)
      • 6.4.13.1. Company Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic initiatives
    • 6.4.14. DeVilbiss Healthcare (a subsidiary of Drive Medical).
      • 6.4.14.1. Company Overview
      • 6.4.14.2. Financial Performance
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic initiatives
    • 6.4.15. React Health (Respiratory Product Line from Invacare Corporation)
      • 6.4.15.1. Company Overview
      • 6.4.15.2. Financial Performance
      • 6.4.15.3. Product Benchmarking
      • 6.4.15.4. Strategic initiatives
    • 6.4.16. O2 Concepts
      • 6.4.16.1. Company Overview
      • 6.4.16.2. Financial Performance
      • 6.4.16.3. Product Benchmarking
      • 6.4.16.4. Strategic initiatives
    • 6.4.17. Nidek Medical Products, Inc.
      • 6.4.17.1. Company Overview
      • 6.4.17.2. Financial Performance
      • 6.4.17.3. Product Benchmarking
      • 6.4.17.4. Strategic initiatives
    • 6.4.18. Omron Corporation
      • 6.4.18.1. Company Overview
      • 6.4.18.2. Financial Performance
      • 6.4.18.3. Product Benchmarking
      • 6.4.18.4. Strategic initiatives
    • 6.4.19. GE Healthcare
      • 6.4.19.1. Company Overview
      • 6.4.19.2. Financial Performance
      • 6.4.19.3. Product Benchmarking
      • 6.4.19.4. Strategic initiatives
    • 6.4.20. Allied Healthcare
      • 6.4.20.1. Company Overview
      • 6.4.20.2. Financial Performance
      • 6.4.20.3. Product Benchmarking
      • 6.4.20.4. Strategic initiatives
    • 6.4.21. Vectura Group Plc.
      • 6.4.21.1. Company Overview
      • 6.4.21.2. Financial Performance
      • 6.4.21.3. Product Benchmarking
      • 6.4.21.4. Strategic initiatives
    • 6.4.22. PARI Respiratory Equipment, Inc.
      • 6.4.22.1. Company Overview
      • 6.4.22.2. Financial Performance
      • 6.4.22.3. Product Benchmarking
      • 6.4.22.4. Strategic initiatives
    • 6.4.23. Aerogen
      • 6.4.23.1. Company Overview
      • 6.4.23.2. Financial Performance
      • 6.4.23.3. Product Benchmarking
      • 6.4.23.4. Strategic initiatives
    • 6.4.24. Beurer
      • 6.4.24.1. Company Overview
      • 6.4.24.2. Financial Performance
      • 6.4.24.3. Product Benchmarking
      • 6.4.24.4. Strategic initiatives
    • 6.4.25. Briggs Healthcare
      • 6.4.25.1. Company Overview
      • 6.4.25.2. Financial Performance
      • 6.4.25.3. Product Benchmarking
      • 6.4.25.4. Strategic initiatives

List of Tables

  • Table 1 North America Anesthesia & Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 2 North America Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 3 U.S Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 4 Canada Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Mexico Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 6 Europe Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 7 Europe Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 8 UK Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 9 Germany Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 France Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 11 Italy Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 12 Spain Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 13 Sweden Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 Denmark Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 15 Norway Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 16 Asia Pacific Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 17 Asia Pacific Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 18 China Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 19 Japan Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 20 India Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 21 Australia Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 South Korea Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 23 Thailand Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 24 Latin America Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 25 Latin America Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 26 Brazil Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Argentina Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 28 MEA Anesthesia And Respiratory Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 29 MEA Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 30 South Africa Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 Saudi Arabia Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 32 UAE Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 33 Kuwait Anesthesia And Respiratory Devices Market, By Product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Aesthesia and respiratory devices market outlook
  • Fig. 9 Aesthesia and respiratory devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Aesthesia and respiratory devices market driver impact
  • Fig. 15 Aesthesia and respiratory devices market restraint impact
  • Fig. 16 Aesthesia and respiratory devices market strategic initiatives analysis
  • Fig. 17 Aesthesia and respiratory devices market: Product movement analysis
  • Fig. 18 Aesthesia and respiratory devices market: Product outlook and key takeaways
  • Fig. 19 Anesthesia devices market, 2021 - 2033 (USD Million)
  • Fig. 20 Anesthesia delivery machines market, 2021 - 2033 (USD Million)
  • Fig. 21 Anesthesia monitors market, 2021 - 2033 (USD Million)
  • Fig. 22 Anesthesia ventilators market, 2021 - 2033 (USD Million)
  • Fig. 23 Anesthesia workstations market, 2021 - 2033 (USD Million)
  • Fig. 24 Anesthesia disposables market, 2021 - 2033 (USD Million)
  • Fig. 25 Anesthesia disposables masks market, 2021 - 2033 (USD Million)
  • Fig. 26 Anesthesia disposable accessories market, 2021 - 2033 (USD Million)
  • Fig. 27 Respiratory devices market, 2021 - 2033 (USD Million)
  • Fig. 28 Positive airway pressure market, 2021 - 2033 (USD Million)
  • Fig. 29 Ventilators market, 2021 - 2033 (USD Million)
  • Fig. 30 Nebulizers market, 2021 - 2033 (USD Million)
  • Fig. 31 Humidifiers market, 2021 - 2033 (USD Million)
  • Fig. 32 Respiratory inhalers market, 2021 - 2033 (USD Million)
  • Fig. 33 Oxygen concentrators market, 2021 - 2033 (USD Million)
  • Fig. 34 Reusable resuscitators market, 2021 - 2033 (USD Million)
  • Fig. 35 Pulse oximeters market, 2021 - 2033 (USD Million)Anesthesia Devices
  • Fig. 36 Capnographs market, 2021 - 2033 (USD Million)
  • Fig. 37 Spirometers market, 2021 - 2033 (USD Million)
  • Fig. 38 Peak flow meters market, 2021 - 2033 (USD Million)
  • Fig. 39 Global aesthesia and respiratory devices market: Regional movement analysis
  • Fig. 40 Global aesthesia and respiratory devices market: Regional outlook and key takeaways
  • Fig. 41 Global anesthesia and respiratory devices market share and leading players
  • Fig. 42 North America market share and leading players
  • Fig. 43 Europe market share and leading players
  • Fig. 44 Asia Pacific market share and leading players
  • Fig. 45 Latin America market share and leading players
  • Fig. 46 Middle East & Africa market share and leading players
  • Fig. 47 North America: SWOT
  • Fig. 48 Europe SWOT
  • Fig. 49 Asia Pacific SWOT
  • Fig. 50 Latin America SWOT
  • Fig. 51 MEA SWOT
  • Fig. 52 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Market share of key market players- aesthesia and respiratory devices market
  • Fig. 81 Key Company Categorization
  • Fig. 82 Company Market Share/Position Analysis, 2024
  • Fig. 83 Strategic Framework